Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Masand, P. S. Articles by Frank, B. Search for Related Content PubMed Citation Articles by Masand, P. S. Articles by Frank, B. Sexual Disorders Antidepressants

Sustained-Release Bupropion for Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study

OBJECTIVE: The authors compared low-dose sustained-release bupropion with placebo for sexual dysfunction induced by selective serotonin reuptake inhibitors (SSRIs). METHOD: Thirty adults who had received SSRIs for at least 6 weeks, who were euthymic, and who had sexual dysfunction as determined by a total score greater than 19 out of a possible 30 on the Arizona Sexual Experience Scale were randomly assigned to receive either 150 mg/day of sustained-release bupropion or placebo at 6:00 p.m. for 3 weeks. RESULTS: There were no significant differences between the sustained-release bupropion and placebo groups as measured by change in Arizona Sexual Experiences Scale or Hamilton Depression Rating Scale scores or side effects. CONCLUSIONS: Future studies should compare higher doses of bupropion for treating sexual dysfunction and should include a greater number of subjects.

This article has been cited by other articles:

				P. J. Lustman, M. M. Williams, G. S. Sayuk, B. D. Nix, and R. E. Clouse Factors Influencing Glycemic Control in Type 2 Diabetes During Acute- and Maintenance-Phase Treatment of Major Depressive Disorder With Bupropion Diabetes Care, March 1, 2007; 30(3): 459 - 466. [Abstract] [Full Text] [PDF]

				J. E. Potter A 60-Year-Old Woman With Sexual Difficulties JAMA, February 14, 2007; 297(6): 620 - 633. [Abstract] [Full Text] [PDF]

				C Mathias, C. Cardeal Mendes, E Ponde de Sena, E Dias de Moraes, C Bastos, M. Braghiroli, G Nunez, R Athanazio, L Alban, H. Moore, et al. An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancer Ann. Onc., December 1, 2006; 17(12): 1792 - 1796. [Abstract] [Full Text] [PDF]

				R. Ginzburg, Y. Wong, and J. S Fader Effect of Bupropion on Sexual Dysfunction Ann. Pharmacother., December 1, 2005; 39(12): 2096 - 2099. [Abstract] [Full Text] [PDF]

				C. A. Orengo, L. Fullerton, and M. E. Kunik Safety and Efficacy of Testosterone Gel 1% Augmentation in Depressed Men With Partial Response to Antidepressant Therapy J Geriatr Psychiatry Neurol, March 1, 2005; 18(1): 20 - 24. [Abstract] [PDF]

				C. C. Carson Erectile Dysfunction: Evaluation and New Treatment Options Psychosom Med, September 1, 2004; 66(5): 664 - 671. [Abstract] [Full Text] [PDF]

				H. B. Miller and J. S. Hunt Female Sexual Dysfunction: Review of the Disorder and Evidence for Available Treatment Alternatives Journal of Pharmacy Practice, June 1, 2003; 16(3): 200 - 208. [Abstract] [PDF]

				R. HIERHOLZER Buproprion and Sexual Dysfunction Am J Psychiatry, April 1, 2002; 159(4): 677 - 677. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us